Volume 89, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



120 patients attending a Hansen's disease public health satellite clinic were evaluated for selected latent co-morbidities, consisting of strongyloidiasis, Chagas disease, hepatitis B, HIV, and tuberculosis, and potential exacerbation by immunosuppressive therapy. Implications for treatment of Hansen's disease are discussed.


Article metrics loading...

Loading full text...

Full text loading...



  1. van Veen NH, Nicholls PG, Smith WC, Richardus JH, , 2008. Corticosteroids for treating nerve damage in leprosy. A Cochrane review. Lepr Rev 79: 361371.
  2. Kahawita IP, Walker SL, Lockwood DN, , 2008. Leprosy type 1 reactions and erythema nodosum leprosum. An Bras Dermatol 83: 7582.[Crossref]
  3. Posey DL, Blackburn BG, Weinberg M, Flagg EW, Ortega L, Wilson M, Secor WE, Sanders-Lewis K, Won K, Maguire JH, , 2007. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees. Clin Infect Dis 45: 13101315.[Crossref]
  4. Pelletier LL, Jr Baker CB, Gam AA, Nutman TB, Neva FA, , 1988. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war. J Infect Dis 157: 573576.[Crossref]
  5. Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M, , 1981. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 80: 14811488.
  6. Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, Bisoffi Z, , 2013. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13: 78.[Crossref]
  7. Ghosh K, Ghosh K, , 2007. Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases. Trans R Soc Trop Med Hyg 101: 11631165.[Crossref]
  8. Centers for Disease Control and Prevention, 1997. Immunization of Health-Care Workers: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 46: 142.
  9. Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Marco VD, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A, , 2007. Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 39: 397408.[Crossref]
  10. Martel N, Cotte L, Trabaud M-A, Trepo C, Zoulim F, Gomes SA, Key A, , 2012. Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape. J Infect Dis 205: 17571761.[Crossref]
  11. Lockwood DNJ, Lambert SM, , 2010. Leprosy and HIV, where are we at? Lepr Rev 81: 169175.
  12. Magill AJ, Reed SG, Strickland GT, , 2000. American Trypanosomiasis. , ed. Hunter's Tropical Medicine and Emerging Infectious Diseases. Eighth edition. Philadelphia, PA: W.B. Saunders Company, 653664.
  13. Walker M, Zunt JR, , 2005. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 40: 10051015.[Crossref]
  14. Trindade MÃ, Carvalho NB, Belfort EC, Pagliari C, Gakiya E, Sakai-Valente NY, Benard G, Shikanai-Yasuda MA, , 2011. A patient with erythema nodosum leprosum and Chagas cardiopathy: challenges in patient management and review of the literature. Am J Trop Med Hyg 84: 973977.[Crossref]

Data & Media loading...

  • Received : 28 Mar 2013
  • Accepted : 15 Jul 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error